Consolidated Planning Corp Pfizer Inc Transaction History

Consolidated Planning Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$26.13 - $33.94 $147,503 - $191,591	-5,645 Reduced 36.59%	9,782 $281,000
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $88,600 - $103,565	-2,761 Reduced 15.18%	15,427 $511,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $426,143 - $493,038	11,798 Added 184.63%	18,188 $667,000
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $32,417 - $42,203	823 Added 14.78%	6,390 $260,000
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $37,032 - $48,341	887 Added 18.95%	5,567 $285,000
Q3 2022 Nov 04, 2022	BUY	$43.76 - $53.42 $36,145 - $44,124	826 Added 21.43%	4,680 $205,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $11,446 - $13,571	-246 Reduced 6.0%	3,854 $202,000
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $20,770 - $25,737	454 Added 12.45%	4,100 $212,000
Q3 2021 Nov 17, 2021	BUY	$39.25 - $50.42 $143,105 - $183,831	3,646 New	3,646 $157,000
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $174,803 - $249,755	-6,467 Closed	0 $0
Q4 2019 Apr 29, 2020	BUY	$32.92 - $37.36 $212,893 - $241,607	6,467 New	6,467 $253,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Consolidated Planning Corp with notifications on news.